Home
Harald G Wiker's picture

Harald G Wiker

Professor
  • E-mailHarald.Wiker@uib.no
  • Phone+47 55 58 61 95
  • Visitor Address
    Haukeland universitetssykehus, Laboratoriebygget
  • Postal Address
    Postboks 7804
    5020 Bergen
  • 2020. Mycobacterial antigens accumulation in foamy macrophages in murine pulmonary tuberculosis lesions: Association with necrosis and making of cavities. Scandinavian Journal of Immunology. 1-13.
  • 2020. Distinct Metabolic Features of Pathogenic Escherichia coli and Shigella spp. Determined by Label‐Free Quantitative Proteomics. Proteomics.
  • 2020. Diagnosis of extrapulmonary tuberculosis using the MPT64 antigen detection test in a high-income low tuberculosis prevalence setting. BMC Infectious Diseases. 1-11.
  • 2019. Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients. PLOS ONE. 1-18.
  • 2019. Repeated bronchoscopy examination of the airway microbiome. European Respiratory Journal.
  • 2019. On the impact of the pangenome and annotation discrepancies while building protein sequence databases for bacteria proteogenomics. Frontiers in Microbiology. 1-13.
  • 2019. Laboratory contamination in airway microbiome studies. BMC Microbiology. 1-13.
  • 2018. Mycobacterial antigen accumulation in foamy macrophages in pulmonary tuberculosis lesions is associated with tissue destruction and disease severity.
  • 2018. Comparative proteomics of enterotoxigenic escherichia coli reveals differences in surface protein production and similarities in metabolism. Journal of Proteome Research. 325-336.
  • 2017. Zoonotic necrotizing myositis caused by Streptococcus equi subsp. zooepidemicus in a farmer. BMC Infectious Diseases. 1-8.
  • 2017. Rapid and specific diagnosis of extrapulmonary tuberculosis by immunostaining of tissues and aspirates with anti-MPT64. Applied immunohistochemistry & molecular morphology (Print). 282-288.
  • 2017. Quantitative proteomic analysis of extracellular matrix extracted from mono- and dual-species biofilms of Fusobacterium nucleatum and Porphyromonas gingivalis. Anaerobe. 133-142.
  • 2017. Protected sampling is preferable in bronchoscopic studies of the airway microbiome. European Respiratory Journal Open Research (ERJ Open Research).
  • 2017. Implementation of a new immunohistochemistry-based test for diagnosing extrapulmonary tuberculosis by detection of mycobacterial antigen MPT64.
  • 2017. Comparing microbiota profiles in induced and spontaneous sputum samples in COPD patients. Respiratory Research. 1-9.
  • 2016. Coordination of metabolism and virulence factors expression of extraintestinal pathogenic Escherichia coli purified from blood cultures of patients with sepsis. Molecular & Cellular Proteomics. 2890-2907.
  • 2015. Phosphoproteomics analysis of a clinical Mycobacterium tuberculosis Beijing isolate: Expanding the mycobacterial phosphoproteome catalog. Frontiers in Microbiology.
  • 2015. Multiplex Analysis of Pro- or Anti-Inflammatory Serum Cytokines and Chemokines in relation to Gender and Age among Tanzanian Tuberculous Lymphadenitis Patients. Tuberculosis research and treatment.
  • 2015. Improving genome annotation of enterotoxigenic Escherichia coli TW10598 by a label-free quantitative MS/MS approach. Proteomics. 3826-3834.
  • 2014. The Bergen COPD microbiome study (MicroCOPD): rationale, design, and initial experiences. European Clinical Respiratory Journal.
  • 2014. Proteogenomics in microbiology: Taking the right turn at the junction of genomics and proteomics. 2360-2675.
  • 2014. Mycobacterial antigens disappear from host tissue during latent Mycobacterium tuberculosis infection.
  • 2014. Effect of non-tuberculous mycobacteria on host biomarkers potentially relevant for tuberculosis management. PLoS Neglected Tropical Diseases.
  • 2014. Differential in vivo expression of mycobacterial antigens in Mycobacterium tuberculosis infected lungs and lymph node tissues. BMC Infectious Diseases.
  • 2013. Antimicrobial effects of beta-glucans and pectin and of the Agaricus blazei-based mushroom extract, AndoSanTM. Examples of mouse models for pneumococcal-, fecal bacterial-, and mycobacterial infections. 10 pages.
  • 2012. Rapid diagnosis of tuberculosis in aspirate, effusions, and cerebrospinal fluid by immunocytochemical detection of Mycobacterium tuberculosis complex specific antigen MPT64. Diagnostic Cytopathology. 782-791.
  • 2012. Proteomic analysis of a multi-resistant clinical Escherichia coli isolate of unknown genomic background. Journal of Proteomics. 1830-1837.
  • 2012. Long-term persistence of BCG Pasteur in lungs of C57BL/6 mice following intranasal infection. Scandinavian Journal of Immunology. 489-499.
  • 2012. Improved signal peptide predictions in mycobacteria? Tuberculosis. 291-292.
  • 2012. Dual-priming oligonucleotides for broad-range amplification of the bacterial 16S rRNA gene directly from human clinical specimens. Journal of Clinical Microbiology. 1289-1294.
  • 2012. Aminoglycoside resistance in clinical Escherichia coli and Klebsiella pneumoniae isolates from Western Norway. Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS). 495-502.
  • 2011. Targeted Vaccibodies against Mycobacterium tuberculosis. Scandinavian Journal of Immunology. 383-384.
  • 2011. Proteogenomic analysis of polymorphisms and gene annotation divergences in prokaryotes using a clustered mass spectrometry-friendly database. Molecular & Cellular Proteomics. 10 pages.
  • 2011. Comparison of membrane proteins of Mycobacterium tuberculosis H37Rv and H37Ra strains. BMC Microbiology.
  • 2011. Characterization of polybacterial clinical samples using a set of group-specific broad-range primers targeting the 16S rRNA gene followed by DNA sequencing and RipSeq analysis. Journal of Medical Microbiology. 927-936.
  • 2011. Bacterial proteins with cleaved or uncleaved signal peptides of the general secretory pathway. Journal of Proteomics. 502-510.
  • 2011. A quantitative view on Mycobacterium leprae antigens by proteomics. 1711-1719.
  • 2011. A proteomic view of mycobacteria. 3118-3127.
  • 2010. Using a Label-free Proteomics Method to Identify Differentially Abundant Proteins in Closely Related Hypo- and Hypervirulent Clinical Mycobacterium tuberculosis Beijing Isolates. Molecular & Cellular Proteomics. 2414-2423.
  • 2010. Serodiagnosis of tuberculous lymnphadenitis using a combination of antigens. Journal of Infection in Developing Countries. 96-102.
  • 2010. Proteomic Approaches to Study Immunity in Infection. 101-114.
  • 2010. MSMSpdbb: providing protein databases of closely related organisms to improve proteomic characterization of prokaryotic microbes. Bioinformatics.
  • 2010. Evidence for waning of latency in a cohort study of tuberculosis. BMC Infectious Diseases.
  • 2010. Definition of novel cell envelope associated proteins in Triton X-114 extracts of Mycobacterium tuberculosis H37Rv. BMC Microbiology.
  • 2010. Comparison of Immune Response in Mice Infected with M-Bovis BCG Russia and M-Bovis BCG Pasteur. Scandinavian Journal of Immunology. 536-536.
  • 2010. Analysis of detergent-insoluble and whole cell lysate fractions of resting neutrophils using high-resolution mass spectrometry. Journal of Proteome Research. 2030-2036.
  • 2009. Virulensfaktorer og immunitet ved mykobakterieinfeksjoner.
  • 2009. Validating divergent ORF annotation of the Mycobacterium leprae genome through a full translation dataset and peptide identification by tandem mass spectrometry. Proteomics. 3233-3243.
  • 2009. The impact of proteomic advances on bacterial gene annotation. 84-92.
  • 2009. Searching for new vaccine candidates - Proteomics against tuberculosis.
  • 2009. Proteomic analysis of total cellular proteins of human neutrophils. Proteome Science.
  • 2009. MPB70 and MPB83 - Major Antigens of Mycobacterium bovis. 492-499.
  • 2009. Kongelig tuberkulose-innblikk.
  • 2009. Identifisering av inntil tre ulike bakteriar direkte frå prøvematerialet ved hjelp av direkte 16S rDNA sekvensering.
  • 2009. Identification and genotyping of the etiological agent of tuberculous lymphadenitis in Ethiopia. Journal of Infection in Developing Countries. 412-419.
  • 2009. HIV Induces both a Down-Regulation of IRAK-4 that Impairs TLR Signalling and an Up-regulation of the Antibiotic Peptide Dermcidin in Monocytic Cells. Scandinavian Journal of Immunology. 264-276.
  • 2009. Fra krysset immunelektroforese til tandem massespektrometri.
  • 2009. Evaluation of signal peptide prediction algorithms for identification of mycobacterial signal peptides using sequence data from proteomic methods.
  • 2009. Evaluation of signal peptide prediction algorithms for identification of mycobacterial signal peptides using sequence data from proteomic methods. Microbiology. 2375-2383.
  • 2009. Direct 16S rDNA sequencing from clinical specimens with special focus on poly-bacterial samples and interpretation of mixed DNA chromatograms. Journal of Clinical Microbiology. 3562-3568.
  • 2009. Diffusion blotting for rapid production of multiple identical imprints from sodium dodecyl sulfate polyacrylamide gel electrophoresis on a solid support. Methods in molecular biology. 35-38.
  • 2009. Differential expression of mycobacterial antigen MPT64, apoptosis and inflammatory markers in multinucleated giant cells and epithelioid cells in granulomas caused by Mycobacterium tuberculosis.
  • 2009. Allergic sensitisation in tuberculosis patients at the time of diagnosis and following chemotherapy. BMC Infectious Diseases. 9 pages.
  • 2009. A label-free method identified differentially abundant proteins in related M.tuberculosis Beijing strains.
  • 2008. Validating divergent ORF annotation in M. tuberculosis datasets using a LTQ-Orbitrap.
  • 2008. Validating divergent ORF annotation in M. tuberculosis datasets using a LTQ-Orbitrap.
  • 2008. Validating divergent ORF annotation in M. tuberculosis datasets using LTQ-Orbitrap.
  • 2008. TB antigen identification.
  • 2008. Rapid and reliable quantification of mycobacteria inside macrophages in vitro and mice using real-time quantitative PCR.
  • 2008. Rapid and reliable quantification of Mycobacteria inside macrophages in vitro and mice mice using real-taime quantitative PCR.
  • 2008. Rapid and Specific Diagnosis of Tuberculous Pleuritis With Immunohistochemistry by Detecting Mycobacterium tuberculosis Complex Specific Antigen MPT64 in Patients From a HIV Endemic Area. Applied immunohistochemistry & molecular morphology (Print). 554-561.
  • 2008. Proteomic analysis of Mycobacterium leprae.
  • 2008. Proteomic analysis of Mycobacterium leprae.
  • 2008. Membrane- and membrane-associated proteins in Triton X-114 extracts of Mycobacterium bovis BCG identified using a combination of gel-based and gel-free fractionation strategies.
  • 2008. Membrane- and membrane-associated proteins in Triton X-114 extracts of Mycobacterium bovis BCG identified using a combination of gel-based and gel-free fractionation strategies.
  • 2008. Membrane- and membrane associated proteins in Triton X-114 extracts of Mycobacterium bovis BCG identified using a combination of gel-based and gel-free fractionation strategies. Proteomics. 1859-1870.
  • 2008. Matallergi - Hvor alvorlig er det? og hva er det man ikke tåler?
  • 2008. Historieløst om kost og leddgikt.
  • 2008. High accuracy mass spectrometry analysis as a tool to verify and improve gene annotation using Mycobacterium tuberculosis as an example. BMC Genomics. 13 pages.
  • 2008. Evaluation of signal peptide prediction algoritms using sequence data from proteomic methods.
  • 2008. Evaluation of signal peptide prediction algorithms using sequence data from proteomic methods.
  • 2008. Etiologi og resistensmønster ved urinveisinfeksjoner.
  • 2008. Estimating the half-life of latent Mycobacterium tuberculosis infection based on the decline of tuberculosis in Norway.
  • 2008. En vaksine mot nye epidemier.
  • 2008. Differential expression of mycobacterial antigen MPT64, apoptosis and inflammatory markers in multinucleated giant cells and epithelioid cells in granulomas caused by Mycobacterium tuberculosis. Virchows Archiv. 449-456.
  • 2008. Diagnosis of tuberculous lymphadenitis in Ethiopia: correlation with culture, histology and HIV status. The International Journal of Tuberculosis and Lung Disease. 1030-1036.
  • 2008. Den norske vaksinen - venn eller fiende?
  • 2008. Antigen analysis of Mycobacterium tuberculosis H37Rv culture filtrate proteins. Scandinavian Journal of Immunology. 245-252.
  • 2008. Antigen analysis of Mycobacterium tuberculosis H37Rv culture filtrate proteins.
  • 2008. Antigen analysis of Mycobacterium tuberculosis H37Rv culture filtrate.
  • 2008. Antigen analysis of Mycobacterium tuberculosis H37Rv culture filtrate.
  • 2007. Vaksiner - Dårligere tuberkulose-vaksine.
  • 2007. The secreted subproteome and determination of cleavage sites for Signal peptidase I.
  • 2007. Reduced apoptosis and increased inflammatory cytokines in granulomas caused by tuberculous compared to non-tuberculous mycobacteria: role of MPT64 antigen in apoptosis and immune response. Clinical and Experimental Immunology. 105-113.
  • 2007. Quantification and characterisation of IgG binding to mould spores by flow cytometry and scanning electron microscopy. JIM - Journal of Immunological Methods. 123-131.
  • 2007. Progress in serodiagnosis of Mycobacterium tuberculosis infection. 176-191.
  • 2007. Nyttig Vaksine.
  • 2007. Innate and specific immune responses to Mycobacterium turberculosis.
  • 2007. Immunohistochemistry for the detection of Mycobacterium tuberculosis complex specific antigen (MPT64) improves the diagnosis of extrapulmonary tuberculosis caused by pathogenic mycobacteria. Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS). 1316-1316.
  • 2007. Immunohistochemical diagnosis of abdominal and lymph node tuberculosis by detecting Mycobacterium tuberculosis complex specific antigen MPT64. Diagnostic Pathology.
  • 2007. Hvor lenge varer tuberkuløs latens?
  • 2007. Detection of mycobacterium tuberculosis specific antigens by immunohistochemical technique: application for improved diagnosis of abdominal tuberculosis.
  • 2007. Correlation of Mycobacterium tuberculosis antigen MPT64 expression and apoptosis in human tuberculosis lesions.
  • 2007. Comprehensive analysis of exported proteins from Mycobacterium tuberculosis H37Rv. Proteomics. 1702-1718.
  • 2007. Antibody response to long-term and high-dose mould-exposed sawmill workers. Scandinavian Journal of Immunology. 711-718.
  • 2007. Analysis of exported proteins from Mycobacterium tuberculosis H37Rv.
  • 2006. Vaksiner mot tuberkulose. Tidsskrift for Den norske legeforening. 2678-2681.
  • 2006. Vaksiner mot tuberkulose. 2678-2681.
  • 2006. Vaccine research in Norway: Status and future prospects.
  • 2006. Vaccine approaches to prevent tuberculosis. Scandinavian Journal of Immunology.
  • 2006. Vaccine approaches to prevent tuberculosis. 243-250.
  • 2006. Secreted antigens of Mycobacterium tuberculosis H37Rv for novel vaccine design.
  • 2006. Secreted antigens of Mycobacterium tuberculosis H37Rv for novel vaccine design.
  • 2006. Revealing the secreted proteome of Mycobacterium tuberculosis H37Rv.
  • 2006. Ny vaksine mot tuberkulose i Bergen.
  • 2006. Mykobakterieinfeksjoner. Naturen. 114-120.
  • 2006. MRSA - status og framtid.
  • 2006. Late breaker: Revealing the secreted proteome of Mycobacterium tuberculosis H37Rv.
  • 2006. Kommentarer til MRSA retningslinjene basert på erfaringer fra epidemien i Hordaland.
  • 2006. Immunohistochemistry using a Mycobacterium tuberculosis complex specific antibody for improved diagnosis of tuberculous lymphadenitis. Modern Pathology. 1606-1614.
  • 2006. Immunoglobulin G antibodies against environmental moulds in a Norwegian healthy population shows a bimodal distribution for Aspergillus versicolor. Vox Sanguinis. 73-73.
  • 2006. Identification of secreted proteins of M. tuberculosis as a basis for vaccine development.
  • 2006. Functional insights from the molecular modelling of a novel two-component system. Biochemical and Biophysical Research Communications - BBRC. 1327-1333.
  • 2006. Cytokine profiles in tuberculosis patients and healthy subjects in response to complex and single antigens of Mycobacterium tuberculosis. FEMS Immunology and Medical Microbiology. 254-261.
  • 2006. Comparing the protein identifications obtained using two-dimensional gel electrophoresis or liquid chromatography mass spectrometry on the secreted proteome of Mycobacterium tuberculosis.
  • 2006. Aldri har flere blitt smittet.
  • 2005. Regulation of expression of MPB70 and MPB83 in Mycobacterium bovis BCG substrains.
  • 2005. Reduced expression of antigenic proteins MPB70 and MPB83 in Mycobacterium bovis BCG strains due to a start codon mutation in sigK. Molecular Microbiology. 1302-1313.
  • 2005. Predicting proteins exported through the general secretory pathway in Mycobacterium tuberculosis H37Rv.
  • 2005. Predicting proteins exported through the general secretory pathway in Mycobacterium tuberculosis H37Rv.
  • 2005. Plenary lecture: The secreted proteomes of Mycobacterium tuberculosis and Mycobacterium leprae.
  • 2005. Molekylær epidemiologi av MRSA utenfor sykehus.
  • 2005. Klistreprotein skaper vaksinekomplikasjoner.
  • 2005. Immunoglobulin G antibodies against environmental moulds in a Norwegian healthy population shows a bimodal distribution for Aspergillus versicolor. Scandinavian Journal of Immunology. 281-288.
  • 2005. Identification of N-terminal peptides by MALDI-TOF of processed proteins secreted through the general secretory pathway.
  • 2005. Identification of N-terminal peptides by MALDI-TOF of processed proteins secreted through the general secretory pathway.
  • 2005. Får vi snart en ny og bedre vaksine mot tuberkulose?
  • 2005. Expression of Mycobacterium bovis antigenic proteins MPB70 and MPB83 is controlled by the alternate sigma factor sigK.
  • 2005. Expression of Mycobacterium bovis antigenic proteins MPB70 and MPB83 is controlled by the alternate sigma factor sigK.
  • 2005. Epidemiological analysis of MRSA in two counties in western Norway.
  • 2005. Epidemiological analysis of MRSA in two counties in Western Norway.
  • 2005. Crystal Structure of Low Molecular Weight Protein Tyrosine Phosphatase (MPtpA) from Mycobacterium tuberculosis at 1.9 Å resolution. Journal of Bacteriology. 2175-2181.
  • 2005. Correlating sequential homology of Mce1A, Mce2A, Mce3A and Mce4A with their possible functions in mammalian cell entry of Mycobacterium tuberculosis by homology modeling.
  • 2005. Correlating sequential homology of Mce1A, Mce2A, Mce3A and Mce4A with their possible functions in mammalian cell entry of Mycobacterium tuberculosis by homology modeling. Tuberculosis. 337-345.
  • 2005. Assay for quantifying mould-specific IgG antibodies in serum by flow cytometry using intact mould spores.
  • 2005. Allergic sensitization in tuberculosis and leprosy patients. International Archives of Allergy and Immunology. 217-224.
  • 2004. Unmatched sequences in public databases - Exemplified by tuberculin-active protein. Scandinavian Journal of Immunology. 607-608.
  • 2004. Mould extracts increase the allergic response to ovalbumin in mice. Clinical and Experimental Allergy. 1634-1641.
  • 2004. Immunodominant B-cell epitope in the Mce1A mammalian cell entry protein of Mycobacterium tuberculosis cross-reacting with glutathione S-transferase. Scandinavian Journal of Immunology. 190-197.
  • 2004. A Case of Peanut Cross-Allergy to Lupine Flour in a Hot Dog Bread. International Archives of Allergy and Immunology. 36-39.
  • 2003. T- and B-cell epitopes in the secreted Mycobacterium bovis antigen MPB70 in mice. Scandinavian Journal of Immunology. 151-161.
  • 2003. Predicted molecular structure of the mammalian cell entry protein Mce1A of Mycobacterium tuberculosis. Biochemical and Biophysical Research Communications - BBRC. 442-447.
  • 2002. Improved cellular and humoral immune responses against Mycobacterium tuberculosis antigens after intramuscular DNA immunisation combined with muscle electroporation. Vaccine. 3370-3378.
  • 2002. Generation of antibodies to the signal peptide of the MPT83 lipoprotein of Mycobacterium tuberculosis. Scandinavian Journal of Immunology. 82-87.
  • 2002. Cross-reaction between mammalian cell entry (Mce) proteins of Mycobacterium tuberculosis. Scandinavian Journal of Immunology. 580-587.
  • 2001. Novel monoclonal antibodies against major antigens of Mycobacterium bovis. Scandinavian Journal of Immunology. 498-502.
  • 2001. Elevated antibody responses in patients with Crohn’s disease against a 14-kDa secreted protein purified from Mycobacterium avium subsp. paratuberculosis. Scandinavian Journal of Immunology. 198-203.
  • 2001. Elevated antibody responses in patients with Crohn's disease against a 14 kDa secreted protein purified from Mycobacterium avium subspecies paratuberculosis. Scandinavian Journal of Immunology. 198-203.
  • 2001. Characterization of the secreted MPT53 antigen of Mycobacterium tuberculosis. Infection and Immunity. 5936-5939.
  • 2000. Distinct differences in repertoires of low-molecular-mass secreted antigens of Mycobacterium avium complex and Mycobacterium tuberculosis. Journal of Clinical Microbiology. 4453-4458.
  • 2000. Alkyl hydroperoxide reductases C and D are major antigens constitutively expressed by Mycobacterium avium subsp. paratuberculosi. Infection and Immunity. 801-808.
  • 1999. The mammalian cell entry operon 1 (mce1) of Mycobacterium leprae and Mycobacterium tuberculosis. Microbial Pathogenesis. 173-177.
  • 1999. Searching for secreted proteins of Mycobacterium leprae. Indian Journal of Leprosy. 19-35.
  • 1999. Demonstration of expression of six proteins of the mammalian cell entry (mce1) operon of Mycobacterium tuberculosis by anti-peptide antibodies, enzyme-linked immunosorbent assay and reverse transcription-polymerase chain reaction. Scandinavian Journal of Immunology. 519-527.
  • 1999. Cloning, expression and significance of MPT53 for identification of secreted proteins of Mycobacterium tuberculosis. Microbial Pathogenesis. 207-219.
  • 1999. Cloning, expression and immunological reactivity of two mammalian cell entry proteins encoded by the mce1 operon pf Mycobacterium tuberculosis. Scandinavian Journal of Immunology. 510-518.
  • 1998. Secreted proteins of Mycobacterium leprae. Scandinavian Journal of Immunology. 577-584.
  • 1998. Protective effect of beta-glucan against Mycobacterium bovis BCG infection in Balb/c mice. Scandinavian Journal of Immunology. 548-553.
  • 1998. MPB70 and MPB83 as indicators of protein localization in mycobacterial cells. Infection and Immunity. 289-296.
  • 1998. Involvement of antilipoarabinomannan antibodies in classical complement activation in tuberculosis. Clinical and Laboratory Immunology. 211-218.
  • 1998. Immunochemical characterization of the MPB70/80 and MPB83 proteins of Mycobacterium bovis. Infection and Immunity. 1445-1452.
  • 1998. Diffusion blotting for rapid production of multiple identical imprints from SDS-PAGE on a solid support. JIM - Journal of Immunological Methods. 77-84.
  • 1998. Comparison of antigen-specific T-cell responses of tuberculosis patients using complex or single antigens of Mycobacterium tuberculosis. Scandinavian Journal of Immunology. 535-543.
  • 1998. B-cell epitopes and quantification of the ESAT-6 protein of Mycobacterium tuberculosis. Infection and Immunity. 717-723.
  • 1997. Molecular cloning, purification, and serological characterization of MPT63, a novel antigen secreted by Mycobacterium tuberculosis. Infection and Immunity. 16-23.
  • 1997. Gene cloning, expression and sequence determination of MPT63, a novel secreted antigen from Mycobacterium tuberculosis. Infection and Immunity. 16-23.
  • 1997. Different localization of the homologous MPB70 and MPB83 proteins of Mycobacterium bovis. Medical principles and practice. 84-90.
  • 1997. A novel mycobacterial antigen relevant to cellular immunity belongs to a family of secreted lipoproteins. Scandinavian Journal of Immunology. 445-451.
  • 1996. Heterogenous expression of the related MPB70 and MPB83 proteins distinguish various substrains of Mycobacterium bovis BCG and Mycobacterium tuberculosis H37Rv. Scandinavian Journal of Immunology. 374-380.
  • 1996. Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infection and Immunity. 16-22.

More information in national current research information system (CRIStin)